SIFLON DRUGS

Company Type: Manufacturer (Factory)

Company Introduction:

SIFLON DRUGS is a pharmaceutical company based in Turkey. It primarily operates as a manufacturer, specializing in the research and development, production, marketing, and sales of a diverse range of pharmaceutical products. The company is committed to delivering high-quality and innovative medicines for various therapeutic areas. SIFLON DRUGS adheres to international quality standards and regulatory requirements throughout its manufacturing processes, serving both domestic and global markets with its pharmaceutical solutions.

SIFLON DRUGS, a company based in Turkey, manufactures and sells a diverse portfolio of pharmaceutical products across numerous therapeutic areas. These products are generally available in various dosage forms including tablets, capsules, syrups, creams, gels, and injectable solutions.

The primary therapeutic areas covered by SIFLON DRUGS' product range are:

Cardiology

Central Nervous System

Dermatology

Gastroenterology

Infectious Diseases

Metabolic Diseases

Musculoskeletal System

Respiratory System

Urology

Oncology

Within these therapeutic categories, SIFLON DRUGS offers a variety of medications such as:

Drugs for cardiovascular conditions like hypertension, heart failure, and cholesterol management.

Medications for neurological and psychiatric disorders including antidepressants, anxiolytics, and antiepileptics.

Dermatological preparations for skin conditions, including corticosteroids, antifungals, and antibiotics.

Gastrointestinal agents such as proton pump inhibitors, antacids, and treatments for irritable bowel syndrome.

A range of antibiotics and antiviral drugs for infectious diseases.

Medications for metabolic disorders, including antidiabetics and lipid-lowering agents.

Analgesic and anti-inflammatory drugs for musculoskeletal pain and inflammation.

Respiratory medications like bronchodilators, antihistamines, and cough and cold remedies.

Urological drugs for conditions such as benign prostatic hyperplasia and urinary tract infections.

Oncological agents and supportive care medications for cancer treatment.